Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines

Sutapa Ray, Pranab K. Sadhukhan, Nirup B. Mandal, Sashi B. Mahato, Hemanta K. Majumder

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A wide variety of biologically active compounds contain indole and quinoline nuclei. A one step synthesis of some novel indolyl quinoline analogs e.g. 2-(2'-Dichloro-acetamidobenzyl)-3-(3' -indolyl)quinoline [1], 2-(2'-Dichloroacetamido-5'-bromo- benzyl)-3'-[3'-(5'-bromoindolyl)]-6-bromo quinoline [2], and 2-(2'-acetamido benzyl)-3-(3'-indolyl)-quinoline [3] has been developed under Friedel-Crafts acylation conditions. The compounds inhibit the relaxation and decatenation reactions catalysed by type I and type II DNA topoisomerases of Leishmania donovani. Among the three synthetic indolyl quinolines, the Br-derivative [2] is most active. The results reported here concerning the inhibition of type I and type II DNA topoisomerases indicate that the compounds act as 'dual inhibitors' of the enzymes and can be exploited for rational drug design in human leishmaniasis.

Original languageEnglish (US)
Pages (from-to)171-175
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume230
Issue number1
DOIs
StatePublished - Jan 3 1997

Fingerprint

DNA Topoisomerases
Quinolines
Leishmania donovani
Type II DNA Topoisomerase
Type I DNA Topoisomerase
Acylation
Leishmaniasis
Drug Design
Enzyme Inhibitors
quinoline
Derivatives
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines. / Ray, Sutapa; Sadhukhan, Pranab K.; Mandal, Nirup B.; Mahato, Sashi B.; Majumder, Hemanta K.

In: Biochemical and Biophysical Research Communications, Vol. 230, No. 1, 03.01.1997, p. 171-175.

Research output: Contribution to journalArticle

Ray, Sutapa ; Sadhukhan, Pranab K. ; Mandal, Nirup B. ; Mahato, Sashi B. ; Majumder, Hemanta K. / Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines. In: Biochemical and Biophysical Research Communications. 1997 ; Vol. 230, No. 1. pp. 171-175.
@article{5c17713ebaaa44cbab0aef0044d9ae07,
title = "Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines",
abstract = "A wide variety of biologically active compounds contain indole and quinoline nuclei. A one step synthesis of some novel indolyl quinoline analogs e.g. 2-(2'-Dichloro-acetamidobenzyl)-3-(3' -indolyl)quinoline [1], 2-(2'-Dichloroacetamido-5'-bromo- benzyl)-3'-[3'-(5'-bromoindolyl)]-6-bromo quinoline [2], and 2-(2'-acetamido benzyl)-3-(3'-indolyl)-quinoline [3] has been developed under Friedel-Crafts acylation conditions. The compounds inhibit the relaxation and decatenation reactions catalysed by type I and type II DNA topoisomerases of Leishmania donovani. Among the three synthetic indolyl quinolines, the Br-derivative [2] is most active. The results reported here concerning the inhibition of type I and type II DNA topoisomerases indicate that the compounds act as 'dual inhibitors' of the enzymes and can be exploited for rational drug design in human leishmaniasis.",
author = "Sutapa Ray and Sadhukhan, {Pranab K.} and Mandal, {Nirup B.} and Mahato, {Sashi B.} and Majumder, {Hemanta K.}",
year = "1997",
month = "1",
day = "3",
doi = "10.1006/bbrc.1996.5874",
language = "English (US)",
volume = "230",
pages = "171--175",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines

AU - Ray, Sutapa

AU - Sadhukhan, Pranab K.

AU - Mandal, Nirup B.

AU - Mahato, Sashi B.

AU - Majumder, Hemanta K.

PY - 1997/1/3

Y1 - 1997/1/3

N2 - A wide variety of biologically active compounds contain indole and quinoline nuclei. A one step synthesis of some novel indolyl quinoline analogs e.g. 2-(2'-Dichloro-acetamidobenzyl)-3-(3' -indolyl)quinoline [1], 2-(2'-Dichloroacetamido-5'-bromo- benzyl)-3'-[3'-(5'-bromoindolyl)]-6-bromo quinoline [2], and 2-(2'-acetamido benzyl)-3-(3'-indolyl)-quinoline [3] has been developed under Friedel-Crafts acylation conditions. The compounds inhibit the relaxation and decatenation reactions catalysed by type I and type II DNA topoisomerases of Leishmania donovani. Among the three synthetic indolyl quinolines, the Br-derivative [2] is most active. The results reported here concerning the inhibition of type I and type II DNA topoisomerases indicate that the compounds act as 'dual inhibitors' of the enzymes and can be exploited for rational drug design in human leishmaniasis.

AB - A wide variety of biologically active compounds contain indole and quinoline nuclei. A one step synthesis of some novel indolyl quinoline analogs e.g. 2-(2'-Dichloro-acetamidobenzyl)-3-(3' -indolyl)quinoline [1], 2-(2'-Dichloroacetamido-5'-bromo- benzyl)-3'-[3'-(5'-bromoindolyl)]-6-bromo quinoline [2], and 2-(2'-acetamido benzyl)-3-(3'-indolyl)-quinoline [3] has been developed under Friedel-Crafts acylation conditions. The compounds inhibit the relaxation and decatenation reactions catalysed by type I and type II DNA topoisomerases of Leishmania donovani. Among the three synthetic indolyl quinolines, the Br-derivative [2] is most active. The results reported here concerning the inhibition of type I and type II DNA topoisomerases indicate that the compounds act as 'dual inhibitors' of the enzymes and can be exploited for rational drug design in human leishmaniasis.

UR - http://www.scopus.com/inward/record.url?scp=0031550251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031550251&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1996.5874

DO - 10.1006/bbrc.1996.5874

M3 - Article

C2 - 9020039

AN - SCOPUS:0031550251

VL - 230

SP - 171

EP - 175

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -